compounds, chromatographic techniques are chosen because the behavior and interaction between molecules in chromatographic and biological systems are very similar. Most molecules cross the cell membranes by passive diffusion; they should be lipophilic enough in order to disseminate through the biological membranes, but also hydrophilic enough to penetrate the cytoplasm. The biological activity of the molecules can be associated with the lipophilic character by retention parameters, which can describe or predict the properties of the active substance. These are either calculated by theoretical methods or are experimentally determined (reverse phase-thin layer chromatography) and help us establish the quantitative structure-retention relationship (QSRR). Furthermore, they express the interaction between the cell membranes and the analyzed molecules [9] [10] [11] [12] [13] .
This prompted us to study the physicochemical properties of this kind of compounds in detail. Herein, we report the synthesis, the study of lipophilicity and the evaluation of the antimicrobial potential of novel 1,3,4-oxadiazolines containing a thiazole ring in their structure, in the hope to provide a deeper insight into the differences in biological activity between them and to suggest synthesis of new active derivatives.
Materials and methods

Chemistry
Solvents and reagents used for synthesis and purification were purchased from Alfa Aesar (Karlsruhe, Germany). All chemicals were of analytical grade. The purity of the synthesized compounds was verified by thin layer chromatography and was carried out on precoated Silica Gel 60F254 sheets using heptan -ethyl-acetate 3:7 as developer and UV absorption for visualization. The melting points were established using an Electrothermal melting point meter and are uncorrected. LC-MS analyses were performed with an Agilent 1100 series and an Agilent Ion Trap SL mass spectrometer.
1 H-NMR was performed on a Bruker Avance NMR spectrometer operating at 500 MHz, in DMSO-d6 as solvent. Chemical shift values were reported relative to tetramethylsilane (TMS) as internal standard. The synthesis of the compounds 1, 2 and 3 was previously reported [14] . The chemical structures of compounds 6a-f, 7a-d are presented in Table I , II. Ten compounds with new structures were synthesized ( Figure  1 ) and characterized.
General procedure for the synthesis of thiazole-5yl-hydrazide-hydrazones (4a-d, 5a-b). [14] [15] [16] To a solution of 2 mmol 3 in 5 ml ethanol and a catalytic amount of glacial acetic acid, an equimolar quantity of aldehyde/ketone was added. The reaction mixture was heated under reflux for 3 h. After cooling, the product was filtered off and washed with water.
General procedure for the synthesis of the thiazolyloxadiazolines (6a-f, 7a-d). [14] [15] [16] A mixture of hydrazide-hydrazone 4 a-d and 5 a-b (1 mmol) and propionic/acetic anhydride (6 ml) was heated under reflux for 6 h. After cooling the reaction mixture was poured into ice cold water. The separated product was filtered, washed with water, dried and recrystallized from ethanol. 
Lipophilicity evaluation
The synthesized oxadiazolines were subjected to RP-TLC in order to obtain the parameters that are necessary for the estimation of their lipophilic properties.
The chromatographic behavior of the compounds was studied by using standard chromatographic plates Silicagel 60 RP-180F 254 S (20x20 cm), with a chemically bound C 18 stationary phase, purchased from Merk (Darmstadt, Germany). Test compounds were dissolved in DMSO to achieve a concentration of 1 mg/ml. These were manually applied as spots at 10 mm from the base and 5 mm from the edges of the plate. The distance between successive spots was 10 mm. The solutions of the investigated compounds were applied using 1 μl standardized chromatographic micropipettes. The mobile phase consisted of a mixture of water and i-propanol. Concentrations of i-propanol in different proportions, between 60% to 80% with 5% increments, were used. The migration distance of the eluent was 85 mm, in all cases. Before the development, the chamber was saturated with the mobile phase for 15 min. The plates were visually inspected under the UV light (364 nm), each zone was clearly marked, its distance was manually measured and was used to calculate the R f values.
RP-TLC provides retention data in the form of R f
(1) and corresponding R M (2) values that can be used to derive chromatographic descriptors for the estimation of lipophilicity: R M0 , b and PCA [17, 18] . R f = x/f (1) x represents the migration distance of the solute and f represents the migration distance of the solvent.
R M0 =lipophilicity estimation parameter R M = retention of a solute b = slope c = concentration of the organic mobile phase modifier (i-propanol)
The lipophilic properties of the investigated compounds were evaluated by using the principal component analysis method (PCA, XL-STAT) [19] . For a better interpretation of the results, these were correlated with cLogP values of the compounds, which were generated by the ChemBioDraw 11.0 software.
Antimicrobial Activity
The newly synthesized compounds were screened for their in vitro antimicrobial activities against four strains of bacteria (Staphylococcus aureus ATCC 49444, Escherichia coli ATCC 25922, Salmonella typhimurium ATCC 14028, Pseudomonas aeruginosa ATCC 27853) and one strain of fungi (Candida albicans ATCC 10231), by the disk diffusion method, according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI, 2012) [20] . For the antibacterial assay, Mueller-Hinton agar medium (Oxoid, Basingstoke, UK) was used and for the antifungal assay, YPD agar (Sigma-Aldrich, Germany) was used. The solutions of the tested compounds were prepared by dissolving each compound in DMSO in order to obtain a concentration of 10 mg/ml. Sterile filter paper disks (6 mm in diameter), impregnated with the solution in DMSO of the test compounds (25μL solution), were placed on the Petri plates, previously seeded "in layer" with the tested bacterial strain inoculums. Gentamicin (25 μL/disk at concentration of 4 μg/mL) was used as positive control for bacteria. Fluconazole (25 μL/disk disk at concentration of 10 mg/mL) was used as positive control for Candida albicans ATCC 10231. A paper disk impregnated with DMSO (25μL/disk) was used as a negative control. The plates that were inoculated with bacteria were incubated for 24 h at 37°C and those inoculated with fungal culture were incubated for 24h at 30°C. The inhibition zone diameters were measured in millimeters. All the tests were performed in duplicate and the average was taken as final reading.
Results
Chemistry
The structures of the newly synthesized compounds were correlated with the data obtained from 1 H NMR and mass spectrometry, given below.
N ' -( 4 -h y d ro x y -3 -m e t h o x y b e n z y l i d e n e ) -2 -(3-(trifluoromethyl)phenyl)-4-methylthiazole-5-carbohydrazide (4a)
C M+1, 100) .
N ' -( 3 -e t h o x y -4 -h y d ro x y b e n z y l i d e n e ) -2 -(3-(trifluoromethyl)phenyl)-4-methylthiazole-5-carbohydrazide (4b)
C 
4-1.4 (m, 10H, cyclohexane). MS m/z(%): 382.5 (M+1, 100).
4-(3-acetyl-5-(-2-(3-(trifluoromethyl)phenyl)-4-methylthiazol-5-yl)-2,3-dihydro-1,3,4-oxadiazol-2-yl)-2-methoxyphenyl acetate (6a)
4-(3-acetyl-5-(-2-(3-(trifluoromethyl)phenyl)-4-methylthiazol-5-yl)-2,3-dihydro-1,3,4-oxadiazol-2-yl)-2-ethoxyphenyl acetate (6b)
2-methoxy-4-(5-(-2-(3-(trifluoromethyl)phenyl)-4-methylthiazol-5-yl)-3-propionyl-2,3-dihydro-1,3,4-oxadiazol-2-yl)phenyl propionate (6c)
2-ethoxy-4-(5-(-2-(3-(trifluoromethyl)phenyl)-4-methylthiazol-5-yl)-3-propionyl-2,3-dihydro-1,3,4-oxadiazol-2-yl)phenyl propionate (6d)
1-(2-(4-bromophenyl)-5-(-2-(3-(trifluoromethyl) phenyl)-4-methylthiazol-5-yl)-1,3,4-oxadiazol-3(2H)-yl) propan-1-one (6e)
-( 2 -( 2 , 4 -d i c h l o r o p h e n y l ) -5 -( -2 -( 3 -(trifluoromethyl)phenyl)-4-methylthiazol-5-yl)-1,3,4-oxadiazol-3(2H)-yl)propan-1-one (6f)
-( 3 -( -2 -( 3 -( t r i f l u o ro m e t h y l ) p h e n y l ) -4 -methylthiazol-5-yl)-4-oxa-1,2-diazaspiro[4.4]non-2-en-1-yl)ethanone (7a)
-( 3 -( -2 -( 3 -( t r i f l u o ro m e t h y l ) p h e n y l ) -4 -
methylthiazol-5-yl)-4-oxa-1,2-diazaspiro[4.5]dec-2-en-1- yl)ethanone (7b) C 20 H 20 F 3 N 3 O 2 S
-( 3 -( -2 -( 3 -( t r i f l u o ro m e t h y l ) p h e n y l ) -4 -methylthiazol-5-yl)-4-oxa-1,2-diazaspiro[4.4]non-2-en-1-yl)propan-1-one (7c)
-( 3 -( -2 -( 3 -( t r i f l u o ro m e t h y l ) p h e n y l ) -4 -methylthiazol-5-yl)-4-oxa-1,2-diazaspiro[4.5]dec-2-en-1-yl)propan-1-one (7d)
C For a correct assessment of the initial data set, the first two principal components were retained; this explains 99.812% of the total information of the initial data. The first component (PC 1 ) explains 98.504% of the total variance and the second 1.308%.
The 2-D scatterplot of the scores corresponding to the first two principal components was generated by the graphic representation of PC 2 =f(PC 1 ) (Figure 2) .
For a better interpretation of the lipophilicity parameters PC 1 and R M0 , cLogP values were generated (Table VI) .
The variations of cLogP, R M0 and PC 1 values in the five mobile phases are represented in Figure 3 . 
